HER2 Support Group Forums - View Single Post

dlaxague · 03-02-2008, 08:55 AM

I see that this question was asked last fall. And now the answers are being sought in a large international trial - see Joe's post about the ALTTO trial, looking at both Tykerb and Herceptin for adjuvant therapy. ( http://her2support.org/vbulletin/sho...ht=altto+trial )
That's a big link - here's the tinyURL: http://tinyurl.com/yq24u8

Either one alone or both (together or sequentially), neo (see link to neo-ALTTO at the alttotrials.com site ), or regular adjuvant, after chemo or concurrent with taxol - very complex trial.

Debbie Laxague

03-02-2008, 08:55 AM	#18
dlaxague Senior Member Join Date: May 2006 Posts: 221	see Joe's post and links of 2/29 I see that this question was asked last fall. And now the answers are being sought in a large international trial - see Joe's post about the ALTTO trial, looking at both Tykerb and Herceptin for adjuvant therapy. ( http://her2support.org/vbulletin/sho...ht=altto+trial ) That's a big link - here's the tinyURL: http://tinyurl.com/yq24u8 Either one alone or both (together or sequentially), neo (see link to neo-ALTTO at the alttotrials.com site ), or regular adjuvant, after chemo or concurrent with taxol - very complex trial. Debbie Laxague